Tamsulosin exposure is significantly increased by the CYP2D6*10/ *10 genotype

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1934-1938
Number of pages5
JournalJournal of Clinical Pharmacology
Volume52
Issue number12
DOIs
StatePublished - Dec 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CYP2D6
  • genetic polymorphism
  • pharmacogenetics
  • pharmacokinetics
  • tamsulosin

Cite this